Skip to main content
Clinical Trials/TCTR20240405003
TCTR20240405003Not yet recruitingPhase 3

A Randomized controlled trial comparing pre-operative high volume lactated Ringer solution combined with human albumin versus standard volume lactated Ringer solution to prevent post-endoscopic retrograde cholangio-pancreatography pancreatitis

avamindradhiraj0 sites300 target enrollmentStarted: April 5, 2024Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Enrollment
300

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to N/A (No limit) (—)
Sex
All

Inclusion Criteria

  • 1. adult patient
  • 2. Underwent ERCP from any cause

Exclusion Criteria

  • 1. no informed consent
  • 2. participant who has history or in active congestive heart failure (higher than New York Heart Association class 2)
  • 3. demonstrate sign of volume overload
  • 4. severe comorbidity ( chronic kidney disease up to stage 3, advanced chronic obstructive pulmonary disease, and poorly controlled blood sugar)
  • 5. history allergy of albumin solution

Investigators

Sponsor
avamindradhiraj

Similar Trials